Search Results

; Adolescents and Young Adults With Cancer; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkin Lymphoma; Lung Cancer Screening; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; Nausea and Vomiting; Non-Hodgkin's Lymphomas; Soft Tissue

taking nilotinib. In addition, her primary care physician was also asked to monitor the patient's blood glucose levels more closely. Her disease responded well to nilotinib, and BCR-ABL1 level decreased to 0.025%. However, she was experiencing nausea

. Mirtazapine may be helpful in treating nausea and insomnia of cancer chemotherapy . Support Care Cancer 2001 ; 9 : 469 – 470 . 25 Musselman DL Lawson DH Gumnick JF : Paroxetine for the prevention of depression induced by high

Canadian Problem Checklist (CPC). The ESAS is a questionnaire that asks patients to rate the severity of 9 common symptoms—pain, fatigue, tiredness, nausea, appetite, shortness of breath, depression, anxiety, and well-being—on a visual analogue scale

more than 55 different NCCN Guidelines for Patients covering every major type of cancer, along with topics like managing cancer-related distress, nausea and vomiting, and survivorship, plus special considerations for adolescents and young adults across

-Induced Immune-Related Adverse Events a Case Report A 62-year-old man presented to the emergency department with nausea and vomiting for 5 days and dizziness for 2 days. His past medical history was significant for BRAF V600E mutation

complained of mild fatigue and abdominal fullness occasionally associated with a dull ache in her abdomen. She had no further black stools, nausea, vomiting, or weight loss. Imatinib was initiated at 400 mg daily. Four days later, she presented to the

, cognitive, emotional, and social), 3 symptom subscales (fatigue, pain, nausea/vomiting), and 6 single-item scales (dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties). The QLQ-C30 also generates a global health status based

, nausea, bloating, and vomiting. Imaging studies revealed multiple PET-avid omental masses, the largest measuring 4.9 × 3.5 × 3.9 cm in the central abdomen ( Figure 1 ), and a large amount of ascites. The ascitic fluid was initially negative for tumor

second vaccine dose. Vaccine recipients were asked to report whether they had experienced any of the following symptoms: tiredness, local pain or swelling at the injection site, joint pain, muscle pain, fever, chills, headache, nausea, or an allergic